title: Interventions for preventing and treating hyperthyroidism in pregnancy.
abstract: BACKGROUND
  Women with hyperthyroidism in pregnancy have increased risks of miscarriage, stillbirth, preterm birth, and intrauterine growth restriction; and they can develop severe pre-eclampsia or placental abruption.
  
  
  OBJECTIVE
  To assess the effects of interventions for preventing or treating hyperthyroidism in pregnant women.
  
  
  METHODS
  We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (28 July 2010).
  
  
  METHODS
  We intended to include randomised controlled trials comparing antithyroid treatments in pregnant women with hyperthyroidism.
  
  
  METHODS
  Two review authors would have assessed trial eligibility and risk of bias, and extracted data.
  
  
  RESULTS
  No trials were located.
  
  
  CONCLUSIONS
  As we did not identify any eligible trials, we are unable to comment on implications for practice, although early identification of hyperthyroidism before pregnancy may allow a woman to choose radioactive iodine therapy or surgery before planning to have a child. Designing and conducting a trial of antithyroid drugs for pregnant women with hyperthyroidism presents formidable challenges. Not only is hyperthyroidism a relatively rare condition, both of the two main drugs used have potential for harm, one for the mother and the other for the child. More observational research is required about the potential harms of methimazole in early pregnancy and about the potential liver damage from propylthiouracil.
authors.affiliation: Discipline of Obstetrics and Gynaecology, School of Paediatrics and Reproductive Health, The University of Adelaide, Medical School North Building, Frome Road, Adelaide, Australia, 5005.
authors.forename: Rachel
authors.initials: R
authors.lastname: Earl
authors.forename: Caroline A
authors.initials: CA
authors.lastname: Crowther
authors.forename: Philippa
authors.initials: P
authors.lastname: Middleton
mesh_terms: D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000517:prevention & control / Q000628:therapy*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000517:prevention & control / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic
references.citation: Lancet Oncol. 2005 Jan;6(1):59-61
references.pmid: 15629277
references.citation: Endocrinol Metab Clin North Am. 2006 Mar;35(1):117-36, vii
references.pmid: 16310645
references.citation: J Clin Endocrinol Metab. 2007 Aug;92(8 Suppl):S1-47
references.pmid: 17948378
references.citation: Best Pract Res Clin Endocrinol Metab. 2004 Jun;18(2):267-88
references.pmid: 15157840
references.citation: Am J Obstet Gynecol. 2004 Jan;190(1):211-7
references.pmid: 14749662
references.citation: Cochrane Database Syst Rev. 2005 Apr 18;(2):CD003420
references.pmid: 15846664
references.citation: Eur J Pediatr. 1992 Aug;151(8):558-9
references.pmid: 1505570
references.citation: N Engl J Med. 2005 Mar 3;352(9):905-17
references.pmid: 15745981
references.citation: Pediatrics. 2001 Sep;108(3):776-89
references.pmid: 11533352
references.citation: BMJ. 2008 Mar 22;336(7645):663-7
references.pmid: 18356235
references.citation: Best Pract Res Clin Endocrinol Metab. 2004 Jun;18(2):289-302
references.pmid: 15157841
references.citation: J Endocrinol Invest. 2002 Jul-Aug;25(7):586-9
references.pmid: 12150331
references.citation: J Clin Endocrinol Metab. 2009 Jun;94(6):1881-2
references.pmid: 19401361